Advanced
  Home Compare Reports

Comparison with Similar Reports

Sterilization Container Systems Market by Product (Sterilization Containers, Accessories), Type (Perforated, Non-Perforated), Material (Stainless Stee...

Publisher:        MarketsandMarkets

# of Pages:        168

Rating: 

1 User License $4,950

Publication Date:  April, 2021

Price:       $4,950 / User License




1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSION & EXCLUSIONS 25
1.3 MARKET SCOPE 26
FIGURE 1 STERILIZATION CONTAINER SYSTEMS MARKET 26
1.3.1 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY 27
1.5 LIMITATIONS 27
1.6 STAKEHOLDERS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
FIGURE 2 RESEARCH DESIGN 28
2.1.1 SECONDARY DATA 29
2.1.1.1 Secondary sources 29
2.1.2 PRIMARY DATA 30
FIGURE 3 PRIMARY SOURCES 30
2.1.2.1 Key data from primary sources 31
2.1.2.2 Key industry insights 31
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 32
2.2 MARKET SIZE ESTIMATION 32
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 33
2.2.1 GROWTH FORECAST 34
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 34
FIGURE 7 TOP-DOWN APPROACH 35
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 36
FIGURE 8 DATA TRIANGULATION METHODOLOGY 36
2.4 ASSUMPTIONS FOR THE STUDY 37
2.5 COVID-19 ECONOMIC ASSESSMENT 37
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 38
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 38
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 39
3 EXECUTIVE SUMMARY 40
FIGURE 11 STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 40
FIGURE 12 STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 41
FIGURE 13 STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2021–2026 (USD MILLION) 41
FIGURE 14 STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 42
FIGURE 15 GEOGRAPHIC SNAPSHOT OF THE STERILIZATION CONTAINER SYSTEMS MARKET 43
4 PREMIUM INSIGHTS 44
4.1 STERILIZATION CONTAINER SYSTEMS MARKET OVERVIEW 44
FIGURE 16 RISING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS & INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH 44
4.2 ASIA PACIFIC: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL & COUNTRY (2021) 45
FIGURE 17 ALUMINUM TO ACCOUNT FOR THE LARGEST SHARE, BY MATERIAL, IN 2021 45
4.3 STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE, 2021–2026 46
FIGURE 18 PERFORATED STERILIZATION CONTAINER SYSTEMS ARE EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 46
4.4 STERILIZATION CONTAINER SYSTEMS MARKET: GEOGRAPHIC SNAPSHOT 46
FIGURE 19 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
FIGURE 20 STERILIZATION CONTAINER SYSTEMS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 47
5.2.1 DRIVERS 48
5.2.1.1 Rising incidence of HAIs 48
5.2.1.2 Increasing number of surgical procedures 48
TABLE 1 NUMBER OF SURGICAL PROCEDURES PERFORMED IN 2016 AND 2018 49
5.2.2 RESTRAINTS 49
5.2.2.1 Use of sterilization wraps & pouches 49
5.2.2.2 Concerns regarding the safety of reprocessed equipment 49
5.2.3 OPPORTUNITIES 50
5.2.3.1 Emerging economies 50
5.3 REGULATORY LANDSCAPE 50
5.4 COVID-19 IMPACT ON THE STERILIZATION CONTAINER SYSTEMS MARKET 51
5.5 TECHNOLOGY ANALYSIS 52
5.6 PRICING ANALYSIS 52
TABLE 2 US: PRICES OF STERILIZATION CONTAINER SYSTEMS, BY TYPE 52
5.7 TRADE ANALYSIS 53
TABLE 3 IMPORT DATA FOR MEDICAL, SURGICAL, OR LABORATORY STERILIZERS,
BY COUNTRY, 2016–2020 (USD MILLION) 53
TABLE 4 EXPORT DATA FOR MEDICAL, SURGICAL, OR LABORATORY STERILIZERS,
BY COUNTRY, 2016–2020 (USD MILLION) 53
5.8 PATENT ANALYSIS 54
5.9 VALUE CHAIN ANALYSIS 54
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 55
5.10 SUPPLY CHAIN ANALYSIS 55
FIGURE 22 DISTRIBUTION: A STRATEGY PREFERRED BY PROMINENT COMPANIES 56
5.11 STERILIZATION CONTAINER SYSTEMS FORM AN INTEGRAL PART OF STERILIZATION EQUIPMENT 57
FIGURE 23 STERILIZATION CONTAINER ECOSYSTEM ANALYSIS 57
5.12 PORTER’S FIVE FORCES ANALYSIS 57
TABLE 5 HIGH CONSOLIDATION IN THE MARKET TO RESTRICT THE ENTRY OF NEW PLAYERS 57
5.12.1 DEGREE OF COMPETITION 58
5.12.2 BARGAINING POWER OF SUPPLIERS 58
5.12.3 BARGAINING POWER OF BUYERS 58
5.12.4 THREAT OF SUBSTITUTES 58
5.12.5 THREAT OF NEW ENTRANTS 58
6 STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT 59
6.1 INTRODUCTION 60
TABLE 6 STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 60
6.2 STERILIZATION CONTAINERS 60
6.2.1 STERILIZATION CONTAINERS COMMAND THE LARGEST MARKET SHARE,
BY PRODUCT 60
TABLE 7 WRAPS VS. CONTAINERS: PURCHASE PARAMETERS 61
TABLE 8 STERILIZATION CONTAINERS MARKET, BY REGION,
2019–2026 (USD MILLION) 61
TABLE 9 NORTH AMERICA: STERILIZATION CONTAINERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 61
TABLE 10 EUROPE: STERILIZATION CONTAINERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 62
TABLE 11 ASIA PACIFIC: STERILIZATION CONTAINERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 62
6.3 ACCESSORIES 62
6.3.1 GROWING AWARENESS OF STERILIZATION IS DRIVING THE DEMAND FOR ACCESSORIES 62
TABLE 12 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION) 63
TABLE 13 NORTH AMERICA: ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 63
TABLE 14 EUROPE: ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 63
TABLE 15 ASIA PACIFIC: ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 64
 
7 STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE 65
7.1 INTRODUCTION 66
TABLE 16 STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 66
7.2 PERFORATED STERILIZATION CONTAINER SYSTEMS 66
7.2.1 PERFORATED STERILIZATION CONTAINER SYSTEMS COMMAND THE LARGEST SHARE OF THE STERILIZATION CONTAINER SYSTEMS MARKET 66
TABLE 17 PERFORATED STERILIZATION CONTAINER SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 66
TABLE 18 NORTH AMERICA: PERFORATED STERILIZATION CONTAINER SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 67
TABLE 19 EUROPE: PERFORATED STERILIZATION CONTAINER SYSTEMS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 67
TABLE 20 ASIA PACIFIC: PERFORATED STERILIZATION CONTAINER SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 67
7.3 NON-PERFORATED STERILIZATION CONTAINER SYSTEMS 68
7.3.1 NON-PERFORATED TYPES ARE USED IN STEAM STERILIZERS USING DYNAMIC AIR REMOVAL CYCLES 68
TABLE 21 NON-PERFORATED STERILIZATION CONTAINER SYSTEMS MARKET,
BY REGION, 2019–2026 (USD MILLION) 68
TABLE 22 NORTH AMERICA: NON-PERFORATED STERILIZATION CONTAINER SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 68
TABLE 23 EUROPE: NON-PERFORATED STERILIZATION CONTAINER SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 69
TABLE 24 ASIA PACIFIC: NON-PERFORATED STERILIZATION CONTAINER SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 69
8 STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY 70
8.1 INTRODUCTION 71
TABLE 25 STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 71
8.2 STERILIZATION CONTAINERS WITH FILTERS 71
8.2.1 STERILIZATION CONTAINERS WITH FILTERS HOLD THE LARGEST SHARE OF THE MARKET 71
TABLE 26 STERILIZATION CONTAINERS WITH FILTERS MARKET, BY REGION,
2019–2026 (USD MILLION) 72
TABLE 27 NORTH AMERICA: STERILIZATION CONTAINERS WITH FILTERS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 72
TABLE 28 EUROPE: STERILIZATION CONTAINERS WITH FILTERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 72
TABLE 29 ASIA PACIFIC: STERILIZATION CONTAINERS WITH FILTERS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 73
8.3 STERILIZATION CONTAINERS WITH VALVES 73
8.3.1 STERILIZATION CONTAINERS WITH VALVES ARE UTILIZED FOR PRE-VACUUM STERILIZATION 73
TABLE 30 STERILIZATION CONTAINERS WITH VALVES MARKET, BY REGION,
2019–2026 (USD MILLION) 73
TABLE 31 NORTH AMERICA: STERILIZATION CONTAINERS WITH VALVES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 74
TABLE 32 EUROPE: STERILIZATION CONTAINERS WITH VALVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 74
TABLE 33 ASIA PACIFIC: STERILIZATION CONTAINERS WITH VALVES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 74
9 STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL 75
9.1 INTRODUCTION 76
TABLE 34 STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 76
9.2 ALUMINUM 76
9.2.1 ALUMINUM STERILIZATION CONTAINERS TO COMMAND THE LARGEST SHARE OF THE MARKET 76
TABLE 35 ALUMINUM STERILIZATION CONTAINERS MARKET, BY REGION,
2019–2026 (USD MILLION) 77
TABLE 36 NORTH AMERICA: ALUMINUM STERILIZATION CONTAINERS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 77
TABLE 37 EUROPE: ALUMINUM STERILIZATION CONTAINERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 77
TABLE 38 ASIA PACIFIC: ALUMINUM STERILIZATION CONTAINERS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 78
9.3 STAINLESS STEEL 78
9.3.1 STAINLESS STEEL OFFERS EXCEPTIONAL MECHANICAL RESISTANCE AND IS LONG LASTING IN NATURE 78
TABLE 39 STAINLESS STEEL STERILIZATION CONTAINER SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 78
TABLE 40 NORTH AMERICA: STAINLESS STEEL STERILIZATION CONTAINER SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 79
TABLE 41 EUROPE: STAINLESS STEEL STERILIZATION CONTAINER SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 79
TABLE 42 ASIA PACIFIC: STAINLESS STEEL STERILIZATION CONTAINER SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 79
9.4 OTHER MATERIALS 80
TABLE 43 OTHER STERILIZATION CONTAINER SYSTEM MATERIALS MARKET, BY REGION, 2019–2026 (USD MILLION) 80
TABLE 44 NORTH AMERICA: OTHER STERILIZATION CONTAINER SYSTEM MATERIALS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 80
TABLE 45 EUROPE: OTHER STERILIZATION CONTAINER SYSTEM MATERIALS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 81
TABLE 46 ASIA PACIFIC: OTHER STERILIZATION CONTAINER SYSTEM MATERIALS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 81
10 STERILIZATION CONTAINER SYSTEMS MARKET, BY REGION 82
10.1 INTRODUCTION 83
TABLE 47 STERILIZATION CONTAINER SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 83
 
10.2 NORTH AMERICA 83
FIGURE 24 NORTH AMERICA: STERILIZATION CONTAINER SYSTEMS MARKET SNAPSHOT 84
TABLE 48 NORTH AMERICA: STERILIZATION CONTAINER SYSTEMS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 49 NORTH AMERICA: STERILIZATION CONTAINER SYSTEMS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 85
TABLE 50 NORTH AMERICA: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 85
TABLE 51 NORTH AMERICA: STERILIZATION CONTAINER SYSTEMS MARKET,
BY MATERIAL, 2019–2026 (USD MILLION) 85
TABLE 52 NORTH AMERICA: STERILIZATION CONTAINER SYSTEMS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 85
10.2.1 US 86
10.2.1.1 The US accounts for the largest share of the North American market 86
TABLE 53 US: KEY MACROINDICATORS 86
TABLE 54 US: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 87
TABLE 55 US: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 87
TABLE 56 US: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 87
TABLE 57 US: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 87
10.2.2 CANADA 88
10.2.2.1 High prevalence of HAIs to support the market growth in the country 88
TABLE 58 CANADA: NUMBER OF SURGICAL PROCEDURES, 2014 VS. 2018 88
TABLE 59 CANADA: KEY MACROINDICATORS 88
TABLE 60 CANADA: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 88
TABLE 61 CANADA: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 89
TABLE 62 CANADA: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL, 2019–2026 (USD MILLION) 89
TABLE 63 CANADA: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 89
10.3 EUROPE 90
TABLE 64 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2014 VS 2018 90
TABLE 65 EUROPE: STERILIZATION CONTAINER SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 66 EUROPE: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 91
TABLE 67 EUROPE: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 91
TABLE 68 EUROPE: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL, 2019–2026 (USD MILLION) 91
TABLE 69 EUROPE: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 92
10.3.1 GERMANY 92
10.3.1.1 Germany held the largest share of the market in Europe in 2020 92
TABLE 70 GERMANY: KEY MACROINDICATORS 92
TABLE 71 GERMANY: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 93
TABLE 72 GERMANY: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 93
TABLE 73 GERMANY: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL, 2019–2026 (USD MILLION) 93
TABLE 74 GERMANY: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 94
10.3.2 UK 94
10.3.2.1 Increasing patient volume due to rising geriatric population to drive the growth in the UK 94
TABLE 75 UK: KEY MACROINDICATORS 94
TABLE 76 UK: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 95
TABLE 77 UK: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 95
TABLE 78 UK: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 95
TABLE 79 UK: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 95
10.3.3 FRANCE 96
10.3.3.1 Favorable government initiatives to support the market growth 96
TABLE 80 FRANCE: KEY MACROINDICATORS 96
TABLE 81 FRANCE: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 96
TABLE 82 FRANCE: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 97
TABLE 83 FRANCE: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL, 2019–2026 (USD MILLION) 97
TABLE 84 FRANCE: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 97
10.3.4 ITALY 98
10.3.4.1 Rising geriatric population in the country to support the market growth 98
TABLE 85 ITALY: KEY MACROINDICATORS 98
TABLE 86 ITALY: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 98
TABLE 87 ITALY: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 99
TABLE 88 ITALY: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 99
TABLE 89 ITALY: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 99
 
10.3.5 SPAIN 100
10.3.5.1 Healthcare service programs drive the market growth in Spain 100
TABLE 90 SPAIN: KEY MACROINDICATORS 100
TABLE 91 SPAIN: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 100
TABLE 92 SPAIN: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 101
TABLE 93 SPAIN: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 101
TABLE 94 SPAIN: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 101
10.3.6 REST OF EUROPE 101
TABLE 95 NUMBER OF SURGICAL PROCEDURES PERFORMED IN ROE COUNTRIES 102
TABLE 96 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 102
TABLE 97 ROE: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 103
TABLE 98 ROE: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 103
TABLE 99 ROE: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 103
TABLE 100 ROE: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 103
10.4 ASIA PACIFIC 104
FIGURE 25 ASIA PACIFIC: STERILIZATION CONTAINER SYSTEMS MARKET SNAPSHOT 104
TABLE 101 ASIA PACIFIC: STERILIZATION CONTAINER SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 102 ASIA PACIFIC: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 105
TABLE 103 ASIA PACIFIC: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 105
TABLE 104 ASIA PACIFIC: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL, 2019–2026 (USD MILLION) 106
TABLE 105 ASIA PACIFIC: STERILIZATION CONTAINER SYSTEMS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 106
10.4.1 JAPAN 106
10.4.1.1 Japan accounted for the largest share of the APAC market 106
TABLE 106 JAPAN: KEY MACROINDICATORS 107
TABLE 107 JAPAN: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
019–2026 (USD MILLION) 107
TABLE 108 JAPAN: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 109 JAPAN: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 108
TABLE 110 JAPAN: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 108
 
10.4.2 CHINA 108
10.4.2.1 Improvements in healthcare infrastructure will favor the market growth 108
TABLE 111 CHINA: KEY MACROINDICATORS 109
TABLE 112 CHINA: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 109
TABLE 113 CHINA: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 114 CHINA: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 110
TABLE 115 CHINA: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 110
10.4.3 INDIA 110
10.4.3.1 Improving healthcare infrastructure and rising number of hospitals to support the market growth 110
TABLE 116 INDIA: KEY MACROINDICATORS 111
TABLE 117 INDIA: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 111
TABLE 118 INDIA: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 111
TABLE 119 INDIA: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 112
TABLE 120 INDIA: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 112
10.4.4 REST OF ASIA PACIFIC 112
TABLE 121 ROAPAC: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 113
TABLE 122 ROAPAC: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 113
TABLE 123 ROAPAC: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL, 2019–2026 (USD MILLION) 113
TABLE 124 ROAPAC: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 114
10.5 REST OF THE WORLD 114
TABLE 125 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2014 VS 2018 114
TABLE 126 ROW: STERILIZATION CONTAINER SYSTEMS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 115
TABLE 127 ROW: STERILIZATION CONTAINER SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 128 ROW: STERILIZATION CONTAINER SYSTEMS MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 115
TABLE 129 ROW: STERILIZATION CONTAINER SYSTEMS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 116
11 COMPETITIVE LANDSCAPE 117
11.1 OVERVIEW 117
FIGURE 26 KEY DEVELOPMENTS IN THE STERILIZATION CONTAINER SYSTEMS MARKET, JANUARY 2018–FEBRUARY 2021 117
11.2 MARKET SHARE ANALYSIS 118
TABLE 130 STERILIZATION CONTAINER SYSTEMS MARKET: DEGREE OF COMPETITION (2019) 118
11.3 COMPANY EVALUATION QUADRANT 119
11.3.1 STARS 119
11.3.2 EMERGING LEADERS 119
11.3.3 PERVASIVE PLAYERS 119
11.3.4 PARTICIPANTS 119
FIGURE 27 STERILIZATION CONTAINER SYSTEMS MARKET: COMPANY EVALUATION QUADRANT, 2019 120
11.4 COMPANY EVALUATION QUADRANT: SMES/START-UPS 121
11.4.1 PROGRESSIVE COMPANIES 121
11.4.2 STARTING BLOCKS 121
11.4.3 RESPONSIVE COMPANIES 121
11.4.4 DYNAMIC COMPANIES 121
FIGURE 28 STERILIZATION CONTAINER SYSTEMS MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS, 2019 122
11.5 COMPANY PRODUCT FOOTPRINT 123
FIGURE 29 COMPANY PRODUCT FOOTPRINT: STERILIZATION CONTAINER SYSTEMS MARKET 123
11.6 COMPANY GEOGRAPHIC FOOTPRINT 124
FIGURE 30 COMPANY GEOGRAPHIC FOOTPRINT: STERILIZATION CONTAINER SYSTEMS MARKET (2019) 124
11.7 COMPETITIVE SCENARIO 125
FIGURE 31 MARKET EVALUATION MATRIX, 2018–2020 125
11.7.1 DEALS 126
TABLE 131 DEALS 126
11.7.2 PRODUCT LAUNCHES 127
TABLE 132 PRODUCT LAUNCHES 127
11.7.3 OTHER DEVELOPMENTS 127
TABLE 133 OTHER DEVELOPMENTS 127
12 COMPANY PROFILES 128
12.1 KEY PLAYERS 128
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 BECTON, DICKINSON AND COMPANY 128
TABLE 134 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 128
FIGURE 32 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 129
12.1.2 B. BRAUN MELSUNGEN AG 131
TABLE 135 B. BRAUN MELSUNGEN: BUSINESS OVERVIEW 131
FIGURE 33 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019) 132
TABLE 136 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD) 132
12.1.3 JOHNSON & JOHNSON 135
TABLE 137 JOHNSON & JOHNSON: BUSINESS OVERVIEW 135
FIGURE 34 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019) 135
12.1.4 INTEGRA LIFESCIENCES 137
TABLE 138 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW 137
FIGURE 35 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2019) 137
12.1.5 MEDLINE INDUSTRIES 140
TABLE 139 MEDLINE INDUSTRIES: BUSINESS OVERVIEW 140
12.1.6 KLS MARTIN GROUP 143
TABLE 140 KLS MARTIN GROUP: BUSINESS OVERVIEW 143
12.1.7 AYGÜN 145
TABLE 141 AYGÜN: BUSINESS OVERVIEW 145
12.1.8 CASE MEDICAL 147
TABLE 142 CASE MEDICAL: BUSINESS OVERVIEW 147
12.1.9 C.B.M. S.R.L. MEDICAL EQUIPEMENT 148
TABLE 143 C.B.M. S.R.L. MEDICAL EQUIPEMENT: BUSINESS OVERVIEW 148
12.1.10 GPC MEDICAL 149
TABLE 144 GPC MEDICAL LTD: BUSINESS OVERVIEW 149
12.1.11 EMED 150
TABLE 145 EMED: BUSINESS OVERVIEW 150
12.1.12 MELAG MEDIZINTECHNIK 151
TABLE 146 MELAG MEDIZINTECHNIK: BUSINESS OVERVIEW 151
12.1.13 RITTER 152
TABLE 147 RITTER: BUSINESS OVERVIEW 152
12.1.14 SUMMIT MEDICAL 153
TABLE 148 SUMMIT MEDICAL: BUSINESS OVERVIEW 153
12.2 OTHER PLAYERS 155
12.2.1 ACE OSTEOMEDICA 155
12.2.2 ELCON MEDICAL INSTRUMENTS 155
12.2.3 GEUDER 156
12.2.4 HU-FRIEDY 157
12.2.5 KEIR SURGICAL 158
12.2.6 MEDIN TECHNOLOGIES 159
12.2.7 NORVAMED MEDICAL 160
12.2.8 STRATEGIC BUSINESS HOLDINGS 161
12.2.9 SYMMETRY SURGICAL 162
12.2.10 THEMPSON 163
12.2.11 TEKNO-MEDICAL OPTIK-CHIRURGIE 164
12.2.12 WORLD PRECISION INSTRUMENTS 165
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
 
13 APPENDIX 166
13.1 INSIGHTS OF INDUSTRY EXPERTS 166
13.2 DISCUSSION GUIDE 167
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 170
13.4 AVAILABLE CUSTOMIZATIONS 172
13.5 RELATED REPORTS 172
13.6 AUTHOR DETAILS 173

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127